9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018

American Diabetes Association - Diabetes care, 2018 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019

American Diabetes Association - Diabetes care, 2019 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …

Aldosterone as a mediator of cardiovascular damage

F Buffolo, M Tetti, P Mulatero, S Monticone - Hypertension, 2022 - Am Heart Assoc
Besides the physiological regulation of water, sodium, and potassium homeostasis,
aldosterone modulates several physiological and pathological processes in the …

Aldosterone, inflammation, immune system, and hypertension

NS Ferreira, RC Tostes, P Paradis… - American journal of …, 2021 - academic.oup.com
Aldosterone is a mineralocorticoid hormone that controls body fluid and electrolyte balance.
Excess aldosterone is associated with cardiovascular and metabolic diseases. Inflammation …

[HTML][HTML] KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease

AK Cheung, TI Chang, WC Cushman… - Kidney …, 2021 - kidney-international.org
The original KDIGO Clinical Practice Guideline for the Management of Blood Pressure in
Chronic Kidney Disease in the chronic kidney disease (CKD) population not receiving …

Primary aldosteronism—a multidimensional syndrome

AF Turcu, J Yang, A Vaidya - Nature Reviews Endocrinology, 2022 - nature.com
Primary aldosteronism is a common cause of hypertension and is a risk factor for
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …

Hypertension management in patients with cardiovascular comorbidities

L Lauder, F Mahfoud, M Azizi, DL Bhatt… - European Heart …, 2023 - academic.oup.com
Arterial hypertension is a leading cause of death globally. Due to ageing, the rising
incidence of obesity, and socioeconomic and environmental changes, its incidence …

Cardiorenal syndrome revisited

F Zannad, P Rossignol - Circulation, 2018 - Am Heart Assoc
Cardiorenal syndromes have been categorized into 5 clinical subtypes based on which
organ is perceived to be the primary precipitant of the vicious and interrelated cycle of …

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

AM Jackson, PS Jhund, IS Anand… - European heart …, 2021 - academic.oup.com
Aims Patients with heart failure and preserved ejection fraction (HFpEF) frequently have
difficult-to-control hypertension. We examined the effect of neprilysin inhibition on 'apparent …

Effects of lifestyle modification on patients with resistant hypertension: results of the TRIUMPH randomized clinical trial

JA Blumenthal, AL Hinderliter, PJ Smith, S Mabe… - Circulation, 2021 - Am Heart Assoc
Background: Although lifestyle modifications generally are effective in lowering blood
pressure (BP) among patients with unmedicated hypertension and in those treated with 1 or …